Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Akt promotes irradiation-induced regulatory T-cell survival in hepatocellular carcinoma.

Li CG, He MR, Wu FL, Li YJ, Sun AM.

Am J Med Sci. 2013 Aug;346(2):123-7. doi: 10.1097/MAJ.0b013e31826ceed0.

PMID:
23255243
[PubMed - indexed for MEDLINE]
2.

Protein kinase B promotes radiation-induced regulatory T cell survival in bladder carcinoma.

Wang M, Gou X, Wang L.

Scand J Immunol. 2012 Jul;76(1):70-4. doi: 10.1111/j.1365-3083.2012.02707.x.

PMID:
22486221
[PubMed - indexed for MEDLINE]
3.

Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.

Du Y, Chen X, Huang ZM, Ye XH, Niu Q.

Asian Pac J Cancer Prev. 2012;13(8):3815-9.

PMID:
23098476
[PubMed - indexed for MEDLINE]
Free Article
4.

Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.

Chen KJ, Lin SZ, Zhou L, Xie HY, Zhou WH, Taki-Eldin A, Zheng SS.

PLoS One. 2011;6(9):e24671. doi: 10.1371/journal.pone.0024671. Epub 2011 Sep 14.

PMID:
21935436
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.

BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166.

PMID:
22559167
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.

Chen X, Du Y, Huang Z.

Immunol Lett. 2012 Nov-Dec;148(1):83-9. doi: 10.1016/j.imlet.2012.09.002. Epub 2012 Sep 19.

PMID:
23000301
[PubMed - indexed for MEDLINE]
7.

Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.

Chen TA, Wang JL, Hung SW, Chu CL, Cheng YC, Liang SM.

PLoS One. 2011;6(8):e23317. doi: 10.1371/journal.pone.0023317. Epub 2011 Aug 3.

PMID:
21826248
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway.

Chen J, Jin X, Chen J, Liu C.

Tumour Biol. 2013 Jun;34(3):1381-9. doi: 10.1007/s13277-013-0746-7. Epub 2013 Apr 12.

PMID:
23580179
[PubMed - indexed for MEDLINE]
9.

Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines.

Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y, Li N, Qi J, Wang L, Shi Y, Qiu S, Fan J, Zha X.

Cell Signal. 2012 Jun;24(6):1229-40. doi: 10.1016/j.cellsig.2012.02.003. Epub 2012 Feb 13.

PMID:
22360859
[PubMed - indexed for MEDLINE]
10.

HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.

Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.

Cancer Lett. 2012 Mar 28;316(2):187-95. doi: 10.1016/j.canlet.2011.10.037. Epub 2011 Nov 4.

PMID:
22182943
[PubMed - indexed for MEDLINE]
11.

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis.

Evert M, Calvisi DF, Evert K, De Murtas V, Gasparetti G, Mattu S, Destefanis G, Ladu S, Zimmermann A, Delogu S, Thiel S, Thiele A, Ribback S, Dombrowski F.

Hepatology. 2012 May;55(5):1473-84. doi: 10.1002/hep.25600. Epub 2012 Apr 4.

PMID:
22271091
[PubMed - indexed for MEDLINE]
12.

Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells.

Shu G, Xie B, Ren F, Liu DC, Zhou J, Li Q, Chen J, Yuan L, Zhou J.

Cell Oncol (Dordr). 2013 Apr;36(2):121-9. doi: 10.1007/s13402-012-0118-0. Epub 2012 Dec 18.

PMID:
23248036
[PubMed - indexed for MEDLINE]
13.

Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.

Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.

Carcinogenesis. 2013 Jun;34(6):1331-42. doi: 10.1093/carcin/bgt060. Epub 2013 Feb 7.

PMID:
23393227
[PubMed - indexed for MEDLINE]
Free Article
14.

HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.

Wachstein J, Tischer S, Figueiredo C, Limbourg A, Falk C, Immenschuh S, Blasczyk R, Eiz-Vesper B.

PLoS One. 2012;7(12):e51747. doi: 10.1371/journal.pone.0051747. Epub 2012 Dec 26.

PMID:
23300563
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.

Zhang HH, Mei MH, Fei R, Liao WJ, Wang XY, Qin LL, Wang JH, Wei L, Chen HS.

Int J Oncol. 2010 Apr;36(4):841-8.

PMID:
20198327
[PubMed - indexed for MEDLINE]
16.

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T, Nakajima A, Hirohashi S.

Clin Cancer Res. 2007 Feb 1;13(3):902-11.

PMID:
17289884
[PubMed - indexed for MEDLINE]
Free Article
17.

Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.

Wang C, Delogu S, Ho C, Lee SA, Gui B, Jiang L, Ladu S, Cigliano A, Dombrowski F, Evert M, Calvisi DF, Chen X.

J Hepatol. 2012 Sep;57(3):577-83. doi: 10.1016/j.jhep.2012.04.026. Epub 2012 May 19.

PMID:
22617155
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.

Cao M, Cabrera R, Xu Y, Firpi R, Zhu H, Liu C, Nelson DR.

Lab Invest. 2007 Jun;87(6):582-90. Epub 2007 Mar 19.

PMID:
17372588
[PubMed - indexed for MEDLINE]
Free Article
19.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
[PubMed - indexed for MEDLINE]
20.

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.

Chen KF, Yu HC, Liu TH, Lee SS, Chen PJ, Cheng AL.

J Hepatol. 2010 Jan;52(1):88-95. doi: 10.1016/j.jhep.2009.10.011. Epub 2009 Oct 23.

PMID:
19913321
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk